Senate panel approves $8 million for premarket review activities
This article was originally published in Clinica
Executive Summary
Senate appropriators have approved what industry is calling a downpayment on a possible user fee agreement. The Senate Appropriations Committee's fiscal year 2003 spending bill for the US FDA earmarks $8m for premarket review activities.